Search Results - Luis Puig

Absolute and Relative Psoriasis Area and Severity Indices (PASI) for Comparison of the Efficacy of Ixekizumab to Etanercept and Placebo in Patients with Moderate-to-severe Plaque P... by Luís Puig, Martin Dossenbach, Lovisa Berggren, Anders Ljungberg, Claus Zachariae

Connect to this object online.

Generalized Pustular Psoriasis: A Review on Clinical Characteristics, Diagnosis, and Treatment by Raquel Rivera-Díaz, Esteban Daudén, José Manuel Carrascosa, Pablo de la Cueva, Luis Puig

Connect to this object online.

Increasing Access to Effective Systemic Treatments in Patients with Moderate-to-Severe Psoriasis: Narrative Review by Giampiero Girolomoni, Laura Savage, Paolo Gisondi, Åke Svensson, Emmanuel Mahé, Matthias Augustin, Luis Puig

Connect to this object online.

Long-term real-world evidence of SB5 (adalimumab biosimilar) treatment in patients with moderate-to-severe psoriasis from the British Association of Dermatologists Biologic and Imm... by Giampiero Girolomoni, Steven R. Feldman, Alexander Egeberg, Luis Puig, Jinah Jung, Hojung Jung, Younju Lee

Connect to this object online.

Dystrophic Calcification in a Patient with Primary Localized Cutaneous Nodular Amyloidosis: An Uncommon Ultrasound Finding by Sergi Planas-Ciudad, Esther Roé Crespo, Juan Francisco Mir-Bonafé, Fania Zamantta Muñoz-Garza, Luis Puig

Connect to this object online.

Real-World Long-Term Effectiveness of Risankizumab Among Patients with Moderate-to-Severe Psoriasis: Analysis from an International Medical Chart Review (RAPID) Study by Andreas Pinter, Ahmed M. Soliman, Irina Pivneva, Roksana Ghanbariamin, Min Yang, Bang Truong, Luis Puig, Mark Lebwohl

Connect to this object online.

Long-term Impact of Ixekizumab on Psoriasis Itch Severity: Results from a Phase III Clinical Trial and Long-term Extension by Alexandra B. Kimball, Thomas Luger, Alice Gottlieb, Luis Puig, Roland Kaufmann, Russel Burge, Chen-Yen Lin, Gil Yosipovitch

Connect to this object online.

Predictors of Local Invasion in Infiltrative Basal Cell Carcinoma: Tumour Budding Outperforms the WHO Subtyping by Maria Teresa Fernandez-Figueras, Noelia Perez-Muñoz, Luis Puig, Rodolfo Posada-Caez, Rosa Ballester Victoria, Martha Henriquez, Eva Musulen

Connect to this object online.

Real-World Discontinuation and Switching Patterns for Interleukin-Inhibitor Treatments in Patients with Moderate-to-Severe Psoriasis in Japan by Yayoi Tada, Ahmed M. Soliman, Kanako Ishii, Ryuta Sakuma, Luis Puig, Matthew Davis, Dominic Nunag, Andreas Pinter, Shinichi Imafuku

Connect to this object online.

Nomenclature and clinical phenotypes of atopic dermatitis by Giampiero Girolomoni, Marjolein de Bruin-Weller, Valeria Aoki, Kenji Kabashima, Mette Deleuran, Luis Puig, Ashish Bansal, Ana B. Rossi

Connect to this object online.

PsoBarrier EU study: a Multicentre, Cross-sectional Survey Investigating the Quality of Psoriasis Care in Four European Countries by Anna Langenbruch, Nicole Mohr, Valerie Andrees, Ihno Kessens, Adam Reich, Magdalena Czarnecka-Operacz, Luis Puig, Esteban Dauden, Lars Iversen, Matthias Augustin

Connect to this object online.

Network meta-analyses comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis at 24-28 and 48-52 weeks by Alexander Egeberg, Lars Erik Kristensen, Luis Puig, Phoebe Rich, Saxon D. Smith, Alyssa Garrelts, Kyoungah See, Thorsten Holzkaemper, Konstantinos Fotiou, Christopher Schuster

Connect to this object online.

Complete Skin Clearance is Associated with the Greatest Benefits to Health-Related Quality of Life and Perceived Symptoms for Patients with Psoriasis by Matthias Augustin, Alice B. Gottlieb, Mark Lebwohl, Andreas Pinter, Richard B. Warren, Luis Puig, Rhys Warham, Jérémy Lambert, Susanne Wiegratz, Balint Szilagyi, Andrew Blauvelt

Connect to this object online.

Progression of Quality of Life in Patients with Plaque Psoriasis Who Achieved Three or More Years of Complete Skin Clearance with Guselkumab Treatment: a Post hoc Analysis of the V... by Luis Puig, Antonio Costanzo, Elke M. G. J. de Jong, Tiago Torres, Richard B. Warren, Robert Wapenaar, Sven Wegner, Patricia Gorecki, Talia Gramiccia, Maria Jazra, Jozefien Buyze, Curdin Conrad

Connect to this object online.

The prevalence of skin diseases in Greece, impact on quality of life and stigmatization: A population‐based survey study by Alexander J. Stratigos, Marie A. Richard, Clio Dessinioti, Carle Paul, Tamar Nijsten, Paolo Gisondi, Carmen Salavastru, Charles Taieb, Myrto Trakatelli, Luis Puig, Thrasyvoulos Tzellos, Dimitrios Ioannides, for the EADV burden of skin diseases project team

Connect to this object online.

Efficacy and safety of netakimab, a novel anti-IL-17 monoclonal antibody, in patients with moderate to severe plaque psoriasis. Results of a 54-week randomized double-blind placebo... by Luis Puig, Andrey L. Bakulev, Muza M. Kokhan, Alexey V. Samtsov, Vladislav R. Khairutdinov, Maria A. Morozova, Nikita A. Zolkin, Ivan V. Kuryshev, Alexey N. Petrov, Antonina V. Artemeva, Arina V. Zinkina-Orikhan

Connect to this object online.

Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure by April Armstrong, Carle Paul, Luis Puig, Wolf Henning Boehncke, Michael Freeman, Hideshi Torii, Kim Papp, Christopher E. M. Griffiths, Andrew Blauvelt, Kristian Reich, Melinda Gooderham, Tadashi Terui, Lisa Renda, Noah Agada, Wen Xu, Gaia Gallo, Mark G. Lebwohl

Connect to this object online.